FATE THERAPEUTICS INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)
The following documents are filed as part of this report:
(1)
Index list to Financial Statements:
| Page | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 42) | 112 |
| Consolidated Balance Sheets | 114 |
| Consolidated Statements of Operations and Comprehensive Loss | 115 |
| Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity | 116 |
| Consolidated Statements of Cash Flows | 117 |
| Notes to Consolidated Financial Statements | 118 |
(2)
Financial Statement Schedules
All other schedules are omitted because they are not required or the required information is included in the financial statements or notes thereto.
(3)
Exhibits
The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.